Recap: ADMA Biologics Q1 Earnings

ADMA Biologics ADMA reported its Q1 earnings results on Wednesday, May 11, 2022 at 04:00 PM.

Here's what investors need to know about the announcement.

ADMA Biologics missed estimated earnings by 25.0%, reporting an EPS of $-0.1 versus an estimate of $-0.08.

Revenue was up $13.05 million from the same period last year.

Last quarter the company missed on EPS by $0.0 which was followed by a 8.67% increase in the share price the next day.

Here's a look at ADMA Biologics's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	-0.09	-0.14	-0.15	-0.17
EPS Actual	-0.09	-0.13	-0.14	-0.16
Revenue Estimate	21.76M	18.72M	16.42M	14.58M
Revenue Actual	26.38M	20.68M	17.83M	16.05M

To track all earnings releases for ADMA Biologics visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar